ID   638-F2
AC   CVCL_C9BZ
DR   Wikidata; Q123030308
RX   PubMed=10974411;
CC   Population: Korean.
CC   Selected for resistance to: ChEBI; CHEBI_46345; 5-fluorouracil (5-FU).
CC   Sequence variation: Mutation; HGNC; HGNC:7029; MET; Simple; p.Asn375Ser (c.1124A>G); ClinVar=VCV000041611; Zygosity=Unspecified (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Heterozygous (from parent cell line).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4004; Gastric adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0102 ! SNU-638
SX   Male
AG   48Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
RX   PubMed=10974411; DOI=10.1016/S0304-3835(00)00535-8;
RA   Chung, Young Min
RA   Park, Sun-Hee
RA   Park, Jong Kuk
RA   Kim, Yoon-Taik
RA   Kang, Yoon-Koo
RA   Yoo, Young Do
RT   "Establishment and characterization of 5-fluorouracil-resistant
RT   gastric cancer cells.";
RL   Cancer Lett. 159:95-101(2000).
//